StockData
Legend Biotech Corp logo

Legend Biotech Corp (LEGN) stock

LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 10, 2026Score 3/30
$16.25+0.14 (+0.87%)

Close on Nov 18, 2026Market cap $3.01BP/E –Yield –

Legend Biotech operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Legend Biotech's operating cash flow for the twelve months ending Jun 30, 2026 was -$89.40M. For fiscal 2025 it was -$100.20M. The highest annual figure on record is $307.68M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$100.20M–
FY2024Dec 31, 2024-$144.00M–
FY2023Dec 31, 2023-$393.30M–
FY2022Dec 31, 2022-$201.28M–
FY2021Dec 31, 2021-$198.47M–
FY2020Dec 31, 2020-$223.01M–
FY2019Dec 31, 2019-$83.07M-127.0%
FY2018Dec 31, 2018$307.68M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$20.90M–
Q1 FY2026Mar 31, 2026-$85.10M–
Q4 FY2025Dec 31, 2025-$12.21M–
Q3 FY2025Sep 30, 2025$28.81M–
Q2 FY2025Jun 30, 2025-$13.20M–
Q1 FY2025Mar 31, 2025-$103.60M-767.6%
Q4 FY2024Dec 31, 2024-$82.05M–
Q3 FY2024Sep 30, 2024-$75.82M–
Q2 FY2024Jun 30, 2024-$1.65M–
Q1 FY2024Mar 31, 2024$15.52M–
Q4 FY2023Dec 31, 2023-$95.67M–
Q3 FY2023Sep 30, 2023-$60.85M–
Q2 FY2023Jun 30, 2023-$97.57M–
Q1 FY2023Mar 31, 2023-$139.22M–
Q4 FY2022Dec 31, 2022-$49.74M–
Q3 FY2022Sep 30, 2022-$72.11M–

More Legend Biotech figures

See a number that looks wrong?